Haemonetics Corp

Official news from Haemonetics, a global healthcare technology company focused on delivering innovative medical solutions to drive better patient outcomes.

[Haemonetics Corp @HaemoneticsCorp]

Cell salvage is one component of a broader patient blood management strategy. The Cell Saver® Elite®+ system is designed to collect, process and wash red blood cells while maintaining red blood cell integrity. See the data: https://t.co/BLau4vWHEi

#CellSalvage

[Haemonetics Corp @HaemoneticsCorp]

Hospitals go above and beyond to provide the highest standards of care, and the technology behind that work should be equally dependable. Our Blood Management Technologies span hemostasis management, cell salvage and transfusion management. Learn more: https://t.co/N8Nqsoftnr

[PPTA @PlasmaProteins]

Congratulations to Michael Ragusa, Vice President of Science & Technology at Haemonetics, recipient of the 2026 Shinji Wada Visionary Award!

The award honors individuals whose longstanding commitment and contributions have elevated the reputation and profile of the source plasma collection industry.

Michael's dedication and vision reflect the leadership and forward-thinking spirit that continue to strengthen and advance the plasma collection community.

Please join PPTA in celebrating Michael on this well-deserved honor!

#PPF2026 #PlasmaProteinForum

[Haemonetics Corp @HaemoneticsCorp]

An exciting milestone for @HaemoneticsIT at TCT 2026! We celebrated the U.S. commercial launch of PerQseal® Elite Vascular Closure System, bringing innovative, patch-based large-bore closure technology to the U.S. market. Learn more: https://t.co/V8VQmjOD4E

[Haemonetics Corp @HaemoneticsCorp]

Trauma care depends on people from different disciplines moving in sync. At #TQIP2026 next week, we’ll be discussing how data supports that coordination to help promote better patient care. https://t.co/iegAWGOWnk

[Haemonetics Corp @HaemoneticsCorp]

Every blood product matters. BloodTrack® solutions help maintain visibility and traceability across the blood supply chain and decrease blood waste. BloodTrack Tx® verifies the right blood is transfused to the right patient at the bedside. https://t.co/NaxCidHFof #PBMWeek

[Haemonetics Corp @HaemoneticsCorp]

Congratulations to Mike Ragusa on receiving PPTA’s Shinji Wada Visionary Award at the #PlasmaProteinForum, honoring his leadership in developing and validating a personalized approach to plasma collection. #PPF2026

[Haemonetics Corp @HaemoneticsCorp]

Haemonetics Corporation Announces Second Quarter Fiscal 2027 Financial Results Available on Investor Relations Website: https://t.co/nGmnnF77YP

[Haemonetics Corp @HaemoneticsCorp]

Patient-centered decision-making is a key principle of #PBM, and it depends on data. The TEG® 6s analyzer shows how a clot forms, strengthens and breaks down, helping clinicians guide targeted therapy based on a patient’s individual coagulation needs. https://t.co/XV8z3Xf9Qo

[Haemonetics Corp @HaemoneticsCorp]

By conserving a patient’s own blood during surgery, the Cell Saver® Elite®+ system can help reduce the needs for allogenic transfusions and associated costs as a valuable component of overall PBM strategy. https://t.co/ftsV5fUGOV

#PatientBloodManagement #PBMWeek #PBM

[Haemonetics Corp @HaemoneticsCorp]

Patient Blood Management is an evidence-based approach to help reduce unnecessary transfusion and promote improved outcomes. We’re recognizing PBM Awareness Week and the clinicians who put these principles into practice every day.

#PatientBloodManagement #PBMWeek #PBM

[Haemonetics Corp @HaemoneticsCorp]

The plasma supply is dependent on donors giving their blood products regularly. On November 4, our Chief Medical Officer, Jan Hartmann, MD, will present at the PPTA Business Forum, covering injury prevention, long-term donor health and donor experience. https://t.co/cdbnP1a0R8

[Haemonetics Corp @HaemoneticsCorp]

Haemonetics will be attending the Society for Women Engineers Annual Conference in Boston next week, from November 5-6. Stop by our booth #10043 during the career fair to meet with our team!

#MakeItMatter #SWE26 #RadiateChange

[Haemonetics Corp @HaemoneticsCorp]

The Cell Saver® Elite® + system gives operators complete control of every process, with intuitive one-button operation to make cell salvage as simple and versatile as possible. Get the details in our brochure: https://t.co/b1GZcg2U1T #AutotransfusionSystem #CellSaverElite

[Haemonetics Corp @HaemoneticsCorp]

Viscoelastic testing with the TEG® 6s analyzer advances #PatientBloodManagement goals by showing clinicians how a clot forms and breaks down, helping inform targeted therapy based on the patient’s specific hemostatic needs. https://t.co/07X3zEqFQK

[Haemonetics Corp @HaemoneticsCorp]

Neurocritical care requires clinicians to weigh bleeding and clotting risks where the margin for error is narrow. These considerations were central to many of our conversations at #NCS2026. If we didn't meet at the show, we welcome the opportunity to chat. https://t.co/no7njp8I9U

[Haemonetics Corp @HaemoneticsCorp]

Blood management continues to evolve thanks to the dedication of professionals in the field. That energy was on full display at #AABB2026. It was a pleasure to reconnect w/ industry experts & hear how teams are working to make transfusion safe & efficient. https://t.co/4wqlYYGPTr

[Haemonetics Corp @HaemoneticsCorp]

The conversations at #ANESTHESIOLOGY2026 reinforced how much anesthesiologists value objective data in the moments that shape a patient's outcome. If we didn't get the chance to connect in San Diego, reach out for more information. https://t.co/NzEzRT4Txg

#ASA #ASAAnnualMeeting

[Haemonetics Corp @HaemoneticsCorp]

From research and public health to individual patient care, meaningful data helps turn information into insight. This #WorldStatisticsDay, we recognize the role data plays in helping inform decisions every day.

#WorldStatisticsDay2026 #Haemonetics #HealthCareData

[Haemonetics Corp @HaemoneticsCorp]

Haemonetics Announces FDA Approval of PerQseal® Elite Vascular Closure System: https://t.co/nQ2TdL4lsK